Hindustan Organic Chemicals Ltd
Incorporated in 1960, Hindustan Organic Chemicals Ltd is in the business of bulk industrial chemicals and chemical intermediates[1]
- Market Cap ₹ 208 Cr.
- Current Price ₹ 31.0
- High / Low ₹ 41.0 / 21.0
- Stock P/E
- Book Value ₹ 152
- Dividend Yield 0.00 %
- ROCE -5.20 %
- ROE -21.6 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Stock is trading at 0.20 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 10.5% over past five years.
- Contingent liabilities of Rs.112 Cr.
- Company might be capitalizing the interest cost
- Company's cost of borrowing seems high
- Working capital days have increased from 41.5 days to 483 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Part of BSE CPSE
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 236 | 178 | 143 | 176 | 275 | 503 | 325 | 407 | 434 | 631 | 704 | 536 | 574 | |
| 382 | 306 | 265 | 335 | 442 | 475 | 384 | 381 | 433 | 625 | 705 | 622 | 645 | |
| Operating Profit | -146 | -129 | -121 | -159 | -167 | 28 | -58 | 27 | 1 | 6 | -1 | -86 | -71 |
| OPM % | -62% | -72% | -85% | -90% | -61% | 6% | -18% | 7% | 0% | 1% | -0% | -16% | -12% |
| 6 | -26 | 15 | 6 | 63 | 117 | 21 | 21 | 34 | 6 | 18 | 526 | 574 | |
| Interest | 43 | 53 | 69 | 98 | 78 | 68 | 58 | 54 | 66 | 67 | 70 | 43 | 6 |
| Depreciation | 19 | 10 | 10 | 9 | 6 | 3 | 3 | 3 | 1 | 1 | 1 | 2 | 2 |
| Profit before tax | -202 | -217 | -185 | -259 | -187 | 73 | -98 | -8 | -32 | -55 | -54 | 395 | 495 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 1% | |
| -202 | -217 | -185 | -259 | -187 | 73 | -98 | -8 | -32 | -55 | -54 | 392 | 492 | |
| EPS in Rs | -28.41 | -32.07 | -26.82 | -38.37 | -27.79 | 10.79 | -14.33 | 0.38 | -4.41 | -7.95 | -8.13 | 58.32 | 73.17 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 11% |
| 3 Years: | 7% |
| TTM: | -1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | -2% |
| 3 Years: | % |
| TTM: | 41% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | -3% |
| 3 Years: | 5% |
| 1 Year: | -23% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | -22% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 |
| Reserves | -707 | -933 | -1,121 | 52 | -33 | 44 | -50 | -36 | -72 | -118 | -119 | 978 | 953 |
| 556 | 698 | 703 | 603 | 609 | 606 | 521 | 518 | 1,226 | 1,286 | 1,362 | 219 | 232 | |
| 412 | 459 | 584 | 1,103 | 1,018 | 837 | 841 | 895 | 258 | 242 | 264 | 304 | 286 | |
| Total Liabilities | 329 | 292 | 234 | 1,825 | 1,662 | 1,555 | 1,379 | 1,444 | 1,479 | 1,478 | 1,575 | 1,568 | 1,539 |
| 151 | 137 | 125 | 1,689 | 154 | 170 | 174 | 136 | 155 | 165 | 226 | 227 | 230 | |
| CWIP | 38 | 11 | 4 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 140 | 143 | 104 | 131 | 1,508 | 1,384 | 1,204 | 1,309 | 1,324 | 1,313 | 1,349 | 1,336 | 1,308 | |
| Total Assets | 329 | 292 | 234 | 1,825 | 1,662 | 1,555 | 1,379 | 1,444 | 1,479 | 1,478 | 1,575 | 1,568 | 1,539 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -13 | -116 | 46 | 59 | -451 | -160 | -81 | -50 | 10 | -13 | -66 | 631 | |
| 11 | 0 | -6 | -0 | 343 | 112 | 164 | 8 | 11 | 7 | 56 | 10 | |
| 3 | 104 | -48 | -59 | 179 | 3 | -90 | 52 | -32 | -10 | 6 | -642 | |
| Net Cash Flow | -0 | -12 | -8 | 0 | 72 | -45 | -8 | 9 | -11 | -16 | -4 | -1 |
| Free Cash Flow | -5 | -116 | 40 | 59 | -109 | -53 | 75 | -49 | 10 | -14 | -67 | 624 |
| CFO/OP | 9% | 90% | -38% | -37% | 270% | -573% | 139% | -185% | 1,182% | -202% | 6,570% | -733% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 18 | 51 | 22 | 19 | 11 | 17 | 14 | 3 | 7 | 11 | 10 | 15 |
| Inventory Days | 150 | 208 | 230 | 319 | 176 | 74 | 95 | 103 | 111 | 44 | 53 | 52 |
| Days Payable | 317 | 406 | 733 | 941 | 477 | 133 | 66 | 30 | 58 | 34 | 50 | 42 |
| Cash Conversion Cycle | -149 | -146 | -481 | -604 | -291 | -43 | 43 | 76 | 60 | 21 | 13 | 24 |
| Working Capital Days | -534 | -744 | -1,311 | -2,729 | 330 | 235 | 79 | -15 | -134 | -159 | -199 | 483 |
| ROCE % | -91% | -17% | 16% | -7% | 9% | 4% | 1% | 1% | -5% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Acetone Production Volume MT ・Standalone data |
|
||||||||||
| Hydrogen Peroxide Production Volume MT ・Standalone data |
|||||||||||
| Phenol Production Volume MT ・Standalone data |
|||||||||||
| Hydrogen Peroxide Plant Capacity Utilization % ・Standalone data |
|||||||||||
| Phenol Plant Capacity Utilization % ・Standalone data |
|||||||||||
| Employee Headcount Number |
|||||||||||
| Safe Man Hours Hours ・Standalone data |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Intimation Regarding Re-Opening Of Phenol & Cumene Plant Of HOCL
2d - BPCL resumed LPG supply; HOCL Phenol and Cumene plant restart activities initiated.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
8 Apr - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026.
-
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
7 Apr - HOC says it is not a large corporate under SEBI circulars; no borrowing or penalty applicable for FY2025-26.
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
7 Apr - HOC confirms it is not a SEBI large corporate; no debt borrowing or penalty applicable.
- Closure of Trading Window 27 Mar
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2]
HOCL was set up as a Government of India enterprise (government holds ~ 58.78% equity stake) under the administrative control of Ministry of Chemicals and Fertilizers. It is the 2nd largest producer of Phenol and Acetone
in India. Company manufactures Hydrogen Peroxide. The raw materials used by HOCL are Benzene and LPG, which come from petroleum refineries. Currently, 500+ units based on HOC’s products are setup across India. It also produces versatile engineering plastic polytetrafluoroethylene (PTFE) through its subsidiary viz. Hindustan Flurocarbons Limited (HFL)